Physician

Shalini Mulaparthi, MD

According to 2025 Medicare claims, Shalini Mulaparthi, MD (NPI: 1427048537) practices hematology/oncology in the Lakeland-Winter Haven, FL market, with the plurality of this provider's patient population coming from Polk, FL. This provider's primary affiliated billing organization is WATSON CLINIC LLP (NPI: 1316940695; TIN: 590704934) and primary practice location at 33805-3013. Mulaparthi is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and Physicians Collaborative Solutions (ACO ID: A5488), participating under the MSSP model.

Mulaparthi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,306 traditional Medicare patients, billed 305,188 HCPCS/CPT codes, and received $4,881,203 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 6,017 prescription claims across 934 beneficiaries totaling $9,068,562 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 79 claims. Open Payments data shows 55 records totaling $3,020. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,149,628 to $9,068,562. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $22,398 to $3,006.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,196	369,966	$3,696,208
2016	1,259	439,354	$4,548,149
2017	1,228	459,998	$5,374,065
2018	1,442	530,856	$6,536,231
2019	1,472	564,335	$6,288,588
2020	1,399	526,236	$6,726,880
2021	1,387	431,364	$6,371,019
2022	1,280	361,328	$5,593,191
2023	1,301	289,755	$5,389,224
2024	1,306	305,188	$4,881,203

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	516	4,512	$2,149,628
2016	584	4,756	$2,634,651
2017	579	5,018	$3,236,520
2018	666	4,939	$3,637,139
2019	723	5,042	$4,936,410
2020	781	6,028	$6,624,479
2021	847	6,155	$6,573,570
2022	826	5,915	$6,176,870
2023	880	5,601	$5,622,346
2024	934	6,017	$9,068,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	64	568	$175,063
2016	52	544	$186,239
2017	23	403	$166,299
2018	36	459	$150,135
2019	38	374	$149,669
2020	N/R	399	$127,431
2021	13	265	$108,005
2022	N/R	140	$4,928
2023	11	93	$10,285
2024	N/R	79	$4,254

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	130	130	$167
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	136	174	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,082	2,328	$94
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	875	1,359	$12
96372	Injection of drug or substance under skin or into muscle	158	963	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	83	2,362	$1,358,508
Lenalidomide	Lenalidomide	68	1,836	$875,202
Ojjaara	Momelotinib Dihydrochloride	31	930	$870,923
Pomalyst	Pomalidomide	36	1,001	$814,175
Ibrance	Palbociclib	40	1,120	$642,661

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	12	$1,738
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	17	$1,302
J8521	Capecitabine, oral, 500 mg	N	N/R	28	$939
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	22	$276

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	53	$1,105	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$1,915	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shalini Mulaparthi, MD?

Tedicare shows public-source Medicare data for Shalini Mulaparthi, MD (NPI 1427048537), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shalini Mulaparthi, MD have ACO affiliation data?

Shalini Mulaparthi, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and Physicians Collaborative Solutions (MSSP, ACO ID A5488).

What billing organization is linked to Shalini Mulaparthi, MD?

Shalini Mulaparthi, MD is linked to WATSON CLINIC LLP (billing NPI 1316940695) in the available physician profile data.

Does Shalini Mulaparthi, MD have Open Payments data?

Shalini Mulaparthi, MD has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.